Systemic inflammatory response syndrome (SIRS): Molecular pathophysiology and gene therapy

147Citations
Citations of this article
109Readers
Mendeley users who have this article in their library.

Abstract

In recent years, extensive basic science research has led to a clear understanding of the molecular mechanisms contributing to the pathophysiology of sepsis. Sepsis is now defined as a systemic inflammatory response syndrome (SIRS) in which there is an identifiable focus of infection. SIRS can be also precipitated by non-infective events such as trauma, pancreatitis, and surgery. As a consequence of an overactive SIRS response, the function of various organ systems may be compromised, resulting in multiple organ dysfunction syndrome (MODS) and death. Production and activation of multiple proinflammatory genes are likely to play a key role in the pathogenesis of MODS development. This review article focuses on the molecular mechanisms and components involved in the pathogenesis of severe sepsis. This includes cellular targets of sepsis-inducing bacterial products and their signaling pathways with a major emphasis on transcription factors and new therapeutic approaches to severe sepsis. ©2006 The Japanese Pharmacological Society.

Cite

CITATION STYLE

APA

Matsuda, N., & Hattori, Y. (2006). Systemic inflammatory response syndrome (SIRS): Molecular pathophysiology and gene therapy. Journal of Pharmacological Sciences. Japanese Pharmacological Society. https://doi.org/10.1254/jphs.CRJ06010X

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free